227 related articles for article (PubMed ID: 17174612)
1. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
[TBL] [Abstract][Full Text] [Related]
2. Current indications for acid suppressants in dyspepsia.
Bytzer P; Talley NJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):385-400. PubMed ID: 11403534
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.
Ford AC; Moayyedi P; Jarbol DE; Logan RF; Delaney BC
Aliment Pharmacol Ther; 2008 Sep; 28(5):534-44. PubMed ID: 18616641
[TBL] [Abstract][Full Text] [Related]
6. Update on the role of drug therapy in non-ulcer dyspepsia.
Talley NJ
Rev Gastroenterol Disord; 2003; 3(1):25-30. PubMed ID: 12684590
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials.
Qadeer MA; Phillips CO; Lopez AR; Steward DL; Noordzij JP; Wo JM; Suurna M; Havas T; Howden CW; Vaezi MF
Am J Gastroenterol; 2006 Nov; 101(11):2646-54. PubMed ID: 17037995
[TBL] [Abstract][Full Text] [Related]
8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
9. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
11. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
Meineche-Schmidt V
Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
[TBL] [Abstract][Full Text] [Related]
12. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
[TBL] [Abstract][Full Text] [Related]
14. Smoking increases the treatment failure for Helicobacter pylori eradication.
Suzuki T; Matsuo K; Ito H; Sawaki A; Hirose K; Wakai K; Sato S; Nakamura T; Yamao K; Ueda R; Tajima K
Am J Med; 2006 Mar; 119(3):217-24. PubMed ID: 16490464
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
Cremonini F; Wise J; Moayyedi P; Talley NJ
Am J Gastroenterol; 2005 Jun; 100(6):1226-32. PubMed ID: 15929749
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
Ford AC; Forman D; Nathan J; Crocombe WD; Axon AT; Moayyedi P
Aliment Pharmacol Ther; 2007 Nov; 26(9):1267-75. PubMed ID: 17944741
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2006 Oct; (4):CD001960. PubMed ID: 17054151
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]